Three-dimensional structures of PDE4D in complex with roliprams and implication on inhibitor selectivity
Huai, Q., Wang, H., Sun, Y., Kim, H.Y., Liu, Y., Ke, H.(2003) Structure 11: 865-873
- PubMed: 12842049 
- DOI: 10.1016/s0969-2126(03)00123-0
- Primary Citation of Related Structures:  
1OYN, 1Q9M - PubMed Abstract: 
Selective inhibitors against the 11 families of cyclic nucleotide phosphodiesterases (PDEs) are used to treat various human diseases. How the inhibitors selectively bind the conserved PDE catalytic domains is unknown. The crystal structures of the PDE4D2 catalytic domain in complex with (R)- or (R,S)-rolipram suggest that inhibitor selectivity is determined by the chemical nature of amino acids and subtle conformational changes of the binding pockets ...